The AB ACC-001 conjugate vaccine trials that ELN has >25% share with PFE and JNJ, initiated in 2007, will be opened this Spring. What odds do you place on success?
Perhaps the events of today, lifting a poison pill, will now allow JNJ to purchase Eln at a big premium. Any thoughts on this possibility.
Market Data 
Markets 
AI
